Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Philadelphia, Pennsylvania–(Newsfile Corp. – December 27, 2024) – National law firm Berger Montague PC informs investors that a lawsuit has been filed against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI ) on behalf of the customers of Isotopes of ASP security between 30 October 2024 and 26 November 2024, inclusive (“Class Period”).
Investors who lost their ASP ISOTOPES (NASDAQ: ASPI ) investment can follow the link below for more information about the case:
CLICK HERE to learn more about the case.
Traders who bought or received ASP ISOTOPES securities during the Group, can, not later FEBRUARY 3, 2025seek to be appointed as the lead representative of the class plaintiff.
Based in Washington, DC, ASP Isotopes is an advanced materials company focused on the production, development and sale of isotopes. The company plans to have multiple isotope enrichment plants currently under development in South Africa.
Investors learned the truth on November 26, 2024, when Fuzzy Panda Research published a report saying ASP Isotopes “is using old laser enhancement technology to masquerade as an advanced new asset.” The report, which featured interviews with former employees and industry experts, raised doubts about the Company’s “proprietary” technology and outlined the Company’s timeline for building its high-quality infrastructure. of high-value uranium (HALEU) as misleading to the point of “insanity.” The report also alleges the Company overstated the value of its agreement with TerraPower and misled investors about Quantum (NASDAQ: ) Leap Energy’s involvement in the proposed TerraPower partnership.
In this news, the price of the Company’s stock decreased by $1.80, or 23.53%, to close at $5.85 per share on November 26, 2024, on unusually heavy trading volume. The price continued to decline the next trading day, falling $0.83 or 14.19%, to close at $5.02 per share on November 27, 2024.
For more information or to learn how to participate in this case, please contact Berger Montague: Andrew Abramowitz at aabramowitz@bm.net or (215) 875-3015, or Peter Hamner at phamner@bm.net or (215) 875-3048, or CLICK HERE.
The lead plaintiff is the representative who represents all the members of the class to conduct the case. The lead plaintiff is usually an investor or a small group of investors who have a significant financial interest and who are also proportionate to the standard of the proposed class of investors. The lead plaintiff appoints counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to participate in any recovery, however, is not affected by whether or not you can act as the lead plaintiff. Consulting with any counselor is not necessary to participate or participate in any recovery achieved in this matter. Each member of the proposed class may have the Court act as the lead plaintiff through counsel of his or her choice, or may choose to do nothing and remain an inactive class member.
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, DC, San Diego, San Francisco and Chicago, has been a pioneer in the security of security groups since it was founded in 1970. decades’ and serves as senior counsel in courts throughout the United States.
To view the source version of this release, please visit https://www.newsfilecorp.com/release/235288
